Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PCL (Poly-ε-caprolactone) Mesh Pleurodesis in Thoracoscopic Treatment of Primary Spontaneous Pneumothorax

NCT03227978 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03227978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PCL (Poly-ε-caprolactone) Mesh Pleurodesis in Thoracoscopic Treatment of Primary Spontaneous Pneumothorax
Lead sponsor
National Taiwan University Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
August 1, 2017
Completion date
July 31, 2019
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pcl pleurodesis